Cutler Group’s Annovis Bio ANVS Stock Holding History

Cutler Group’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-600	Closed	-$6.55K	–	2249
2023 Q4	$11K	Buy	+600	New	+$5.32K	﹤0.01%	2312

Other funds holding ANVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WFAG

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return

RAM

Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $552M AUM 26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Cutler Group's ANVS Position: Q1 2024 in Review

Cutler Group sold out of Annovis Bio (ANVS) in Q1 2024, closing a stake of 600 shares — an estimated $6.55K sold.

Cutler Group first reported a position in ANVS in Q4 2023 and held it in 1 quarter. The position peaked at $11K in Q4 2023. 32 funds tracked by Wall St. Rank hold ANVS as of Q1 2024.

Cutler Group reported no remaining Annovis Bio position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 600 Annovis Bio shares in Q1 2024, an estimated $6.55K.
Cutler Group first reported a position in Annovis Bio in Q4 2023 and held it in 1 quarter.
Cutler Group's Annovis Bio position peaked at $11K in Q4 2023.
32 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.